Munich – September 09, 2026 -- Sky Labs presented new clinical data at ESC Congress 2026 showing its ring-shaped blood pressure monitor, CART, achieves an approximately 80% data-usability rate in continuous 24-hour monitoring of patients with atrial fibrillation, addressing a measurement gap left by traditional cuff-based devices in patients with irregular pulse or severe blood pressure fluctuations.

Munich – September 09, 2026 -- Sky Labs unveiled new clinical data at ESC Congress 2026 showing its ring-shaped blood pressure monitor CART achieved an 80% data evaluability rate in 24-hour monitoring of patients with atrial fibrillation (AFib), addressing a gap where conventional cuffs struggle with irregular pulses.

Munich – September 09, 2026 -- Sky Labs presented new clinical trial data for its ring-based blood pressure monitor, CART, at the ESC Congress 2026 in Munich on September 7, showing an 80% data evaluability rate in continuous monitoring of atrial fibrillation (AFib) patients and high correlation with standard ambulatory blood pressure monitoring (ABPM) in severe heart failure cases.

Shanghai – September 08, 2026 -- Pulnovo Medical's pulmonary artery denervation (PADN) system reduced the risk of clinical worsening by 51% in patients with pulmonary hypertension linked to left heart disease (PH-LHD), according to results from the PADN-HF-PH trial presented at the European Society of Cardiology (ESC) Congress 2026 and simultaneously published in The New England Journal of Medicine.

Shanghai – September 08, 2026 -- Pulnovo Medical's pulmonary artery denervation (PADN) system reduced the risk of clinical worsening by 51% in patients with pulmonary hypertension linked to left heart disease, according to results from the PADN-HF-PH trial presented at the European Society of Cardiology (ESC) 2026 Congress and published simultaneously in The New England Journal of Medicine (NEJM).